RYANODINE RECEPTOR-1-DEPENDENT CALCIUM SIGNALING PATHWAY AS A NOVEL TUMORIGENIC MECHANISM AND THERAPEUTIC TARGET OF OVARIAN CANCER

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators